1.Changes of Peptide with Tyrosine and Ghrelin Levels in Preterm Infants and Their Relationships with Body Weight
xia-fang, CHEN ; zhen-juan, HE
Journal of Applied Clinical Pediatrics 2006;0(14):-
Objective To study the role of peptide with tyrosine(PYY) and ghrelin in infants by comparing the difference and correlation of PYY,ghrelin levels and body weight in preterm infants and full-term infants.Methods Radio-immunity was used to determine serum PYY and ghrelin levels in 20 preterm infants in their first,3rd and 7th days,and also in 20 full-term infants at the 7th day.Body weight were recorded in the both groups.Then the levels of 2 hormone were analyzed the correlations with the body weight.Results Serum PYY and ghrelin levels increased remarkably in preterm infants as compared with those in full-term infants[full-term infants:PYY was(601.9?206.2) ng?L-1;ghrelin was(1 064.5?208.6) ng?L-1;preterm infants:PYY was(812.4?153.8) ng?L-1;ghrelin was(1 485.4?409.2) ng?L-1,Pa
3.CT-guided 125I seeds implantation for the treatment of lymph node metastasis nearby the iliac vessels:preliminary clinical observation
Huimin YU ; Hongtao ZHANG ; Wei HE ; Aixia SUI ; Juan WU ; Zhen GAO ; Juan WANG
Journal of Interventional Radiology 2015;24(12):1072-1076
Objective To discuss the feasibility, efficacy and complications of CT-guided 125I seed implantation for the treatment of lymph node metastasis nearby the iliac vessels.Methods The clinical data of twelve patients with para-iliac vessel lymph node metastasis, who had been treated with CT-guided 125I seed implantation, were retrospectively analyzed. A total of 12 lesions were detected; the diameter ≤6 cm was seen in seven lesions, and the diameter >6 cm was seen in five lesions. Using computer treatment planning system, the source distribution was calculated. Under CT guidance 125I seeds with the activity of 0.4-0.7 mci were implanted into the metastatic lymph nodes with a seed interval of 0.5-1.0 cm. CT scan was performed immediately after implantation to check the distribution of seeds as well as the possible complications. After the treatment, D90 (90%prescription dose received by target volume) was ≥75 Gy in 6 patients and <75 Gy in other 6 patients. Two months after the treatment CT reexamination was employed, and imaging evaluation was conducted according to WHO Response Evaluation Criteria in Solid Tumors. Results CT-guided 125I seed implantation was successfully accomplished in all 12 patients. Two months after the treatment, the evaluation of the therapeutic effect showed that complete remission (CR) was obtained in 0 patient, partial remission (PR) in 8 patients, stable disease in 3 patients and progress disease in one patient;and the total effect rate(CR+PR) was 66.7%. The local control rate was 91.7%. In eight patients the pain that was caused by metastatic lymph nodes was significantly relieved within 1-14 days after 125I implantation treatment. Before the treatment three patients had lower limb edema, and in two of them the lower limb edema was obviously relieved within 1-14 days after the treatment. All patients were followed up for 3-39 months, and the median follow-up time was 11 months. One-year survival rate was 41.7%. No severe complications such as massive hemorrhage, infection, myelosuppression or seed displacement occurred. Conclusion For the treatment of para-iliac vessel lymph node metastasis, CT-guided 125I seed implantation is safe and feasible. Better curative effect may be achieved when the diameter of the metastatic lymph node is<6 cm and the peripheral radiation dose is>75 Gy.
4.The research progress on role of miRNAs in methamphetamine addiction
Yongwang HE ; Juan LI ; Yiqing ZHOU ; Xiangyue ZHAO ; Genmeng YANG ; Ning ZHANG ; Xiaofeng ZENG ; Zhen LI
Chinese Pharmacological Bulletin 2017;33(8):1056-1060
The methamphetamine(METH)addiction is a compensatory adaptation of the central nervous system after the long-term exposure to METH in the molecular,cellular,neuronal loop function and brain structure.As a new type of post transcriptional regulatory molecules and regulatory factors,miRNAs are a large number of regulatory factors in the central nervous system.Studies have shown that miRNAs play an important role in the regulation of METH addiction.This paper is to review and summarize the expression features and the regulatory role of miRNAs in METH addiction,as well as the different expression of miRNAs in different tissues and organs.The aim of this paper is to provide a reference for further study on the role of miRNAs molecules in METH addiction and the discovery of new drug targets.
5.Analysis of Clinical Distribution and Drug-resistance of Pathogen in Urinary Tract Infection in Wuhan
Zhen LI ; Congrong LI ; Xuan CAI ; Juan LI ; Qing WU ; Ziqi HE
Journal of Modern Laboratory Medicine 2014;(5):135-137,140
Objective To investigate the tendency of distribution and drug-resistance of the causative organisms of urinary tract infections(UTIs)in Wuhan,and provide reliable evidence for clinical treatment.Methods Analyzed the 5 378 stains of pathogen isolated from the urine of patients in hospital.The bacteria isolates were identified with BD Phoenix-100 while can-dida isolates were identified by color plate.Results A total of 5 378 stains of pathogen had been isolated.There were 2 945 stains (54.8%)of Gram-negative bacteria,1 657 stains (30.8%)of Gram-positive bacteria,776 stains (14.4%)of fungus. The rates of Escherichiacoli resistant to penicillin were highest (>83%),and there were no carbapenem-resistant strains. There were vancomycin and linezolid-resistant Enterococcispp strains,the lowest dection rates of which were 0.3%.The de-tection rate of MRCNS was over 83%.Conclusion Escherichiacoli was the most common pathogens of urinary tract infec-tion,and theβ-lactamase inhibitor complex can be used as empirical treatment of E.coli infections.Thedetection rate of MRCNS increased,which shoud be kept a watchful eye on.
6.The clinical significance of cystatin B in hepatocellular carcinoma.
Juan HE ; Zhen-bo FENG ; Mei-hua WU
Chinese Journal of Hepatology 2010;18(12):936-937
Adult
;
Aged
;
Carcinoma, Hepatocellular
;
blood
;
diagnosis
;
Case-Control Studies
;
Cystatin B
;
blood
;
Female
;
Humans
;
Liver Neoplasms
;
blood
;
diagnosis
;
Male
;
Middle Aged
7.Function and mechanism of neurotensin (NTS) and its receptor 1 (NTSR1) in occurrence and development of tumors.
Huan-rong HU ; Zhen DONG ; Liang YI ; Xiao-yan HE ; Yan-li ZHANG ; Ya-ling LIU ; Hong-juan CUI
China Journal of Chinese Materia Medica 2015;40(13):2524-2536
As a neuropeptide, neurotensin (NTS) is widely expressed in central and peripheral nervous system, which is mainly mediated byneurotensin receptor1 (NTSR1) to activate the related downstream signaling pathways. After summarized the function and mechanism of NTS/NTSR1 in various malignant tumors, we found that NTS/NTSR1 played essential roles during tumor initiation and development. NTS/NTSR1 regulates tumor initiation, proliferation, apoptosis, metastasis and differentiation mainly through three pathways, including IP3/Ca2+ /PKC/MAPKs pathway, MMPs/EGFR/MAPKs (PI3K/Akt) pathway, or Rho-GTPsaes and non-receptor tyrosine kinase pathway. Besides, NTS/NTSR1 is also regulated by some upstream pathways and some traditional Chinese medicine preparations and traditional Chinese medicine therapies. In this article, we summarized the function of NTS/NTSR1 and its mechanisms, and discussed the prospective in its application to clinical diagnosis and drugs targeting.
Animals
;
Humans
;
Medicine, Chinese Traditional
;
Neoplasms
;
etiology
;
Neurotensin
;
chemistry
;
physiology
;
Receptor, Epidermal Growth Factor
;
physiology
;
Receptors, Neurotensin
;
chemistry
;
physiology
;
Signal Transduction
;
physiology
;
rhoA GTP-Binding Protein
;
physiology
8.Construction and expression of an anti-EGFR/anti-KDR bispecific single-chain diabody.
Ya-qiong ZHOU ; Juan ZHANG ; Hai-zhen JIN ; Yuan HE ; Tong WANG ; Min WANG
Acta Pharmaceutica Sinica 2012;47(10):1317-1322
Bispecific antibodies have been exploited as both cancer immunodiagnostics and cancer therapeutics, which have shown promises in clinical trials in cancer imaging and therapy. To improve the anti-tumor effect, an scDb (bispecific single-chain diabody) was constructed from the variable domain genes of two scFvs (single-chain variable fragment antibodies) directed against human EGFR (epidermal growth factor receptor) and VEGFR2 (vascular endothelial growth factor receptor 2) extracellular domains. The anti-EGFR/ anti-KDR scDb was constructed into pHEN2 plasmid and expressed in Escherichia coli HB2151 host. After purification by one-step affinity chromatography of IMAC, scDb protein was characterized by Western blotting. The yield of scDb protein was 570 microg per liter medium. scDb bound to EGFR as efficiently as the parental antibody scFv-E10, while a little bit weaker than the parental antibody scFv-AK404R when bound to KDR. In conclusion, the scDb protein could bind both EGFR and KDR specifically and could be applied for further anti-tumor research.
Antibodies, Bispecific
;
biosynthesis
;
genetics
;
Escherichia coli
;
metabolism
;
Humans
;
Plasmids
;
Protein Binding
;
Receptor, Epidermal Growth Factor
;
immunology
;
Single-Chain Antibodies
;
biosynthesis
;
genetics
;
Vascular Endothelial Growth Factor Receptor-2
;
immunology
9.The clinical value of the ultrafine needle CO_2 splenoportography
Gang DENG ; Wen FANG ; Zhen-Sheng LIU ; Guo-Zhao LI ; Shi-Cheng HE ; Jin-He GUO ; Guang-Yu ZHU ; Hui-Juan DING ; Zhi-Ping SHEN ; Gao-Jun TENG
Chinese Journal of Radiology 2001;0(04):-
Objective To evaluate the clinical efficacy of percutaneous ultra-fine needle CO_2 splenoportography (CO_2-SP).Methods CO_2-SP and 3D-CE-MRA were performed in 36 patients.The imaging quality of the methods was compared by a scoring criterion setup based on the visualization of the trunk,intrahepatic branches of the portal vein and collateral vessels.Results Transient mild abdominal discomfort was presented in 19 patients(52.8% )receiving CO_2-SP.One patient developed snbcapsular splenic hematoma and was discharged with clinical stability several days later after conservative treatment. The imaging quality of the intrahepatic branches of the portal vein with CO_2-SP was much more superior to 3D-CE-MRA (the score was 232 and 198 respectively,t=4.52,P0.05 ).Conclusion Ultrafine needle CO_2-SP is a minimally invasive and safe procedure,able to provide dynamic and clearer imaging of the intrahepatic branches of the portal vein.
10.Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.
San Gang WU ; Jia Yuan SUN ; Zhen Yu HE ; Qiong Hua CHEN ; Juan ZHOU
Journal of Gynecologic Oncology 2017;28(6):e81-
OBJECTIVE: To investigate the clinicopathological features and outcomes between node-negative, early-stage cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) after hysterectomy. METHODS: Patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stages I–IIA cervical SCC and AC between 1988 and 2013 were retrospectively reviewed using the Surveillance, Epidemiology, and End Results database. We used propensity score-matching to balance patient baseline characteristics. Univariate and multivariate Cox regression analyses were used for prognostic analyses of cause-specific survival (CSS) and overall survival (OS). RESULTS: A total of 9,858 patients were identified, comprising 6,117 patients (62.1%) and 3,741 (37.9%) patients with cervical SCC and AC, respectively. Compared with cervical SCC, cervical AC cases were more likely to be younger, diagnosed after 2000, white, and have well-differentiated and FIGO stage IB1 disease. For SCC and AC, the 10-year CSS rates were 93.4% and 94.7%, respectively (p=0.011), and the 10-year OS rates were 89.6% and 92.2%, respectively (p<0.001). Multivariate analysis revealed that age, ethnicity, tumor grade, and FIGO stage were independent prognostic factors of CSS and OS, but that histologic subtype was not associated with CSS and OS. In the propensity score-matched patient population, univariate and multivariate analyses also showed that histologic subtype was not associated with survival outcomes. CONCLUSION: Cervical AC has equivalent survival to cervical SCC in node-negative, early-stage disease after hysterectomy and lymphadenectomy.
Adenocarcinoma*
;
Carcinoma, Squamous Cell*
;
Epidemiology
;
Epithelial Cells*
;
Gynecology
;
Humans
;
Hysterectomy*
;
Lymph Node Excision
;
Multivariate Analysis
;
Obstetrics
;
Prognosis
;
Retrospective Studies
;
Uterine Cervical Neoplasms